Dexcom (DXCM) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -515.00 |
| Dec 31, 2025 | -722.00 |
| Sep 30, 2025 | -748.00 |
| Jun 30, 2025 | -335.00 |
| Mar 31, 2025 | -646.00 |
| Dec 31, 2024 | -794.00 |
| Sep 30, 2024 | -257.00 |
| Jun 30, 2024 | 102.00 |
| Mar 31, 2024 | 83.00 |
| Dec 31, 2023 | -245.00 |
| Sep 30, 2023 | 71.00 |
| Jun 30, 2023 | -63.00 |
| Mar 31, 2023 | -209.00 |
| Dec 31, 2022 | -306.00 |
| Sep 30, 2022 | -458.00 |
| Jun 30, 2022 | -431.00 |
| Mar 31, 2022 | -282.00 |
| Dec 31, 2021 | -48.00 |
| Sep 30, 2021 | 70.00 |
| Jun 30, 2021 | 782.00 |
| Mar 31, 2021 | 347.00 |
| Dec 31, 2020 | 43.00 |
| Sep 30, 2020 | -373.00 |
| Jun 30, 2020 | -793.00 |
| Mar 31, 2020 | -56.00 |
| Dec 31, 2019 | -192.00 |
| Sep 30, 2019 | -610.00 |
| Jun 30, 2019 | -717.00 |
| Mar 31, 2019 | -309.00 |
| Dec 31, 2018 | -4.00 |
| Sep 30, 2018 | -112.00 |
| Jun 30, 2018 | 165.00 |
| Mar 31, 2018 | 874.00 |
| Dec 31, 2017 | 1,690.00 |
| Sep 30, 2017 | 3,243.00 |
| Jun 30, 2017 | 2,121.00 |
| Mar 31, 2017 | 1,936.00 |
| Dec 31, 2016 | 2,040.00 |
| Sep 30, 2016 | 2,323.00 |
| Jun 30, 2016 | 666.00 |
| Mar 31, 2016 | 2,871.00 |
| Dec 31, 2015 | 2,503.00 |
| Sep 30, 2015 | 4,189.00 |
| Jun 30, 2015 | 3,247.00 |